IUS Publications
Found 12 results
Filters: Author is Sezer, Abas [Clear All Filters]
, “Biomaterials in personalized drug delivery: innovations, challenges, and future directions”, PeerJ, vol. 14, p. e20982, 2026.
, “Advancing medicine with biomaterials: Innovations in regenerative technologies and clinical applications”, Bioengineering Studies, vol. 6, no. 1, pp. 24 - 50, 2025.
, “The impact of COVID-19 on autoimmune diseases”, in Progress in Molecular Biology and Translational Science Navigating the Complexities of SARS-CoV-2 Immunobiology: The Science Behind the COVID-19 Pandemic, Elsevier, 2025, pp. 315-345.
, “Targeting Lymphoma With Benzoxazole Derivatives: Effects on Viability and Protein Expression in Cell Lines”, Chemistry & Biodiversity, 2025.
, “The intersection of microbiome and autoimmunity in long COVID-19: Current insights and future directions”, Cytokine & Growth Factor Reviews, 2024.
, “Polyphenol stability and bioavailability in cell culture medium: Challenges, limitations and future directions”, International Journal of Biological Macromolecules, vol. 279, p. 135232, 2024.
, “Single and Combinatorial Effects of Metformin and Thymoquinone in Diffuse Large B Cell Lymphoma Cells”, Chemistry & Biodiversity, vol. 22, no. 3, 2024.
, “Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells”, Croatica Chemica Acta, vol. 96, no. 1, pp. 59 - 68, 2023.
, “Breast cancer research: in vitro models, markers, and in silico analysis - a narrative review”, Bioengineering Studies, vol. 4, no. 2, pp. 14 - 23, 2023.
, “COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence”, Biomedicines, vol. 11, no. 5, p. 1469, 2023.
, “A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives”, Journal of Genetic Engineering and Biotechnology, vol. 20, no. 1, 2022.
, “Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis”, Viruses, vol. 14, no. 10, p. 2105, 2022.